Biotech

All Articles

FDA fragments adcomm for Applied's uncommon health condition medicine

.After dismissing the choice date for Applied Therapeutics' metabolic disorder medicine govorestat, ...

Novo inks $600M NanoVation deal to examine hereditary drugs ex-liver

.Novo Nordisk is proceeding its own press right into hereditary medications, accepting compensate Na...

Innovent links cytokine to colorectal cancer cells responses

.Innovent Biologics has actually produced the instance that its gate inhibitor-cytokine fusion prote...

Merck, Daiichi ADC reaches objective in stage 3 lung cancer cells research study

.A period 3 trial of Daiichi Sankyo as well as Merck &amp Co.'s HER3-directed antibody-drug conjugat...

Rakovina grows artificial intelligence concentrate with collab to decide on cancer intendeds

.Five months after Rakovina Rehabs pivoted towards artificial intelligence, the cancer-focused biote...

Ascendis' dwarfism medication favorites in stage 3, intimidates BioMarin

.Ascendis Pharma has become a prospective threat to BioMarin's Voxzogo, disclosing phase 3 developme...

Despite ph. 3 skip, Alkeus views road in advance for eye illness asset

.Though Alkeus Pharmaceuticals' dental eye condition property failed to significantly minimize geogr...

Kairos goes social along with $6M IPO to cash trials of cancer cells medication

.Along with a trio of biotechs reaching the Nasdaq on Friday, it was actually easy to miss out on a ...

Vaccine and Keytruda combo effective in squamous cell cancer

.Immune system gate inhibitors are the superheroes of cancer treatment. Medicines like Bristol Myers...

Cue Biopharma queues up J&ampJ vet as CBO-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our roundup of substantial management hirings, shootings ...